Lunai Bioworks Inc. (LNAI) Form 8-K Material Events
Lunai Bioworks Inc. (LNAI) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LNAI
CIK: 1527728
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Sadler, Gibb & Associates, LLC
Auditor SinceSince 6/30/2018 12:00:00 AM
Lead Engagement PartnerMark Sperry
Audit LocationDraper, Utah, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-15 | — | SCHEDULE 13D/A Filing | 0001214659-26-012970 | View SEC Doc Filr Page |
| 10-K | 2026-10-13 | 2026-06-30 | FORM 10-K | 0001731122-26-001339 | View SEC Doc Filr Page |
| 8-K | 2026-10-09 | 2026-10-09 | FORM 8-K | 0001731122-26-001333 | View SEC Doc Filr Page |
| NT 10-K | 2026-09-29 | 2026-06-30 | FORM NT 10-K | 0001731122-26-001299 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-17 | — | SCHEDULE 13G Filing | 0002143778-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | FORM 8-K | 0001731122-26-000871 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-11 | FORM 8-K | 0001731122-26-000865 | View SEC Doc Filr Page |
| 8-K | 2026-05-20 | 2026-05-20 | FORM 8-K | 0001731122-26-000759 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | FORM 10-Q | 0001731122-26-000749 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-08 | FORM 8-K | 0001731122-26-000718 | View SEC Doc Filr Page |
| 8-K/A | 2026-05-11 | 2026-04-27 | FORM 8-K/A | 0001731122-26-000705 | View SEC Doc Filr Page |
| DEFR14A | 2026-05-01 | — | FORM DEFR14A | 0001731122-26-000655 | View SEC Doc Filr Page |
| 8-K | 2026-05-01 | 2026-04-27 | FORM 8-K | 0001731122-26-000653 | View SEC Doc Filr Page |
| 8-K | 2026-04-28 | 2026-04-27 | FORM 8-K | 0001731122-26-000623 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | FORM DEFA14A | 0001731122-26-000622 | View SEC Doc Filr Page |
| DEFR14A | 2026-04-15 | — | FORM DEFR14A | 0001731122-26-000570 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-13 | 2026-04-13 | FORM DEF 14A | 0001731122-26-000559 | View SEC Doc Filr Page |
| PRE 14A | 2026-04-02 | 2026-04-02 | FORM PRE 14A | 0001731122-26-000528 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-24 | FORM 8-K | 0001731122-26-000502 | View SEC Doc Filr Page |
| 8-K | 2026-03-05 | 2026-02-27 | FORM 8-K | 0001731122-26-000345 | View SEC Doc Filr Page |
| 8-K | 2026-02-23 | 2026-02-17 | FORM 8-K | 0001731122-26-000282 | View SEC Doc Filr Page |
| 10-Q | 2026-02-17 | 2025-12-31 | FORM 10-Q | 0001731122-26-000253 | View SEC Doc Filr Page |
| 8-K | 2026-02-12 | 2026-02-06 | FORM 8-K | 0001731122-26-000221 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-12-09 | — | SCHEDULE 13D/A Filing | 0001214659-25-017804 | View SEC Doc Filr Page |
| 424B5 | 2025-12-03 | — | FORM 424B5 | 0001731122-25-001626 | View SEC Doc Filr Page |